GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers…
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers…
SoFi’s Latest Campaign, Featuring LA Chargers Quarterback Justin Herbert, Highlights the Unique Ways It Helps…
Global Perspectives: Data I/O’s CEO Discusses Critical Topics and Emerging Market Trends from Automotive Technologies…
BRAINTREE, Mass.–(BUSINESS WIRE)–M7 Global Partners, a consortium of leading IT consulting firms, today announced the…
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical…
SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™…
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12,…
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12,…
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON…
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy FARMINGTON…